These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 24380388)

  • 1. Hemostatic profile and thromboembolic risk in healthy dogs treated with prednisone: a randomized controlled trial.
    Romão FG; Campos EF; Mattoso CR; Takahira RK
    BMC Vet Res; 2013 Dec; 9():268. PubMed ID: 24380388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of serum storage, anti-inflammatory oral doses of prednisone, and spontaneous hyperadrenocorticism on serum glutamate dehydrogenase activity in dogs.
    Peta HG; Carr AP; Myers SL; Joffe DJ; Kidney BA
    Vet Clin Pathol; 2007 Mar; 36(1):25-9. PubMed ID: 17311190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Oral Prednisone Administration on Serum Cystatin C in Dogs.
    Muñoz J; Soblechero P; Duque FJ; Macías-García B; Ruiz P; Zaragoza C; Barrera R
    J Vet Intern Med; 2017 Nov; 31(6):1765-1770. PubMed ID: 28921665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of immunosuppressive agents on the hemostatic system in normal dogs.
    Thomason JM; Archer TM; Wills RW; Mackin AJ
    J Vet Intern Med; 2018 Jul; 32(4):1325-1333. PubMed ID: 29749651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of desmopressin acetate administration on primary hemostasis in Doberman Pinschers with type-1 von Willebrand disease as assessed by a point-of-care instrument.
    Callan MB; Giger U
    Am J Vet Res; 2002 Dec; 63(12):1700-6. PubMed ID: 12492285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of coagulation and potential biochemical markers for hypercoagulability in canine hyperadrenocorticism.
    Pace SL; Creevy KE; Krimer PM; Brainard BM
    J Vet Intern Med; 2013; 27(5):1113-20. PubMed ID: 23952553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of coagulation status in dogs with naturally occurring canine hyperadrenocorticism.
    Klose TC; Creevy KE; Brainard BM
    J Vet Emerg Crit Care (San Antonio); 2011 Dec; 21(6):625-32. PubMed ID: 22316255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of short-term anti-inflammatory glucocorticoid treatment on clinicopathologic, echocardiographic, and hemodynamic variables in systemically healthy dogs.
    Masters AK; Berger DJ; Ware WA; Langenfeld NR; Coetzee JF; Mochel JPM; Ward JL
    Am J Vet Res; 2018 Apr; 79(4):411-423. PubMed ID: 29583045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombin Generation Assay and Hemostatic Profile for Elucidating Hypercoagulability in Endogenous Canine Hyperadrenocorticism.
    Vargas-Mora SE; Romão FG; Dos Santos B; Carvalho MDG; Duarte RCF; De Marco Bernardes V; Lopes PA; Takahira RK
    Top Companion Anim Med; 2021 Nov; 45():100581. PubMed ID: 34509666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the buccal bleeding time and platelet glass bead retention as assays of hemostasis in the dog: the effects of acetylsalicylic acid, warfarin and von Willebrand factor deficiency.
    Brassard JA; Meyers KM
    Thromb Haemost; 1991 Feb; 65(2):191-5. PubMed ID: 2053106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of thrombelastography over time in dogs with hyperadrenocorticism.
    Kol A; Nelson RW; Gosselin RC; Borjesson DL
    Vet J; 2013 Sep; 197(3):675-81. PubMed ID: 23838206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of oxypolygelatin and dextran 70 on hemostatic variables in dogs.
    Glowaski MM; Moon-Massat PF; Erb HN; Barr SC
    Vet Anaesth Analg; 2003 Oct; 30(4):202-10. PubMed ID: 12925177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrent hyperadrenocorticism and diabetes mellitus in dogs.
    Miceli DD; Pignataro OP; Castillo VA
    Res Vet Sci; 2017 Dec; 115():425-431. PubMed ID: 28759861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the efficacy of prednisone and cyclosporine for treatment of dogs with primary immune-mediated polyarthritis.
    Rhoades AC; Vernau W; Kass PH; Herrera MA; Sykes JE
    J Am Vet Med Assoc; 2016 Feb; 248(4):395-404. PubMed ID: 26829271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized, controlled trial of budesonide and prednisone for the treatment of idiopathic inflammatory bowel disease in dogs.
    Dye TL; Diehl KJ; Wheeler SL; Westfall DS
    J Vet Intern Med; 2013; 27(6):1385-91. PubMed ID: 24112400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of prednisone on haemostasis in leishmaniotic dogs treated with meglumine antimoniate and allopurinol.
    Cortese L; Pelagalli A; Piantedosi D; Mastellone V; Di Loria A; Lombardi P; Ciaramella P; Avallone L
    Vet J; 2008 Sep; 177(3):405-10. PubMed ID: 17629526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of canine hyperadrenocorticism on coagulation parameters.
    Rose L; Dunn ME; Bédard C
    J Vet Intern Med; 2013; 27(1):207-11. PubMed ID: 23278831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myotonia associated with hyperadrenocorticism in two dogs.
    Swinney GR; Foster SF; Church DB; Malik R
    Aust Vet J; 1998 Nov; 76(11):722-4. PubMed ID: 9862060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of 2 Doses for ACTH Stimulation Testing in Dogs Suspected of or Treated for Hyperadrenocorticism.
    Aldridge C; Behrend EN; Kemppainen RJ; Lee-Fowler TM; Martin LG; Ward CR; Bruyette D; Pannu J; Gaillard P; Lee HP
    J Vet Intern Med; 2016 Sep; 30(5):1637-1641. PubMed ID: 27425787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complications and concurrent disease associated with canine hyperadrenocorticism.
    Nichols R
    Vet Clin North Am Small Anim Pract; 1997 Mar; 27(2):309-20. PubMed ID: 9076910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.